Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

by Servier CDMO

Servier Group is proud to announce that it will develop its presence in the US market through the oncology therapeutic area. Servier CDMO, in accordance with the group’s strategy, continues to develop its services for High Potent drugs in API and drug product.

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Servier Group is proud to announce that it will develop its presence in the US market through the oncology therapeutic area. Servier CDMO, in accordance with the group’s strategy, continues to develop its services for High Potent drugs in API and drug product.